【摘要】 目的:检测CD147和基质金属蛋白酶(MMP)-2,3,9在卵巢癌中的表达,了解其与卵巢癌临床病理特征之间的关系,探讨卵巢癌中CD147与MMP-2、MMP-3和MMP-9表达的相关性。方法:用免疫组化SP法对40例卵巢癌组织,9例良性卵巢上皮性肿瘤组织中CD147和MMP-2、MMP-3、MMP-9的表达情况进行检测。结果:CD147和MMP-2、MMP-3及MMP-9在卵巢癌中的阳性表达率分别为92.5%,100%,100%和95%,阳性表达与病理分级和临床分期有关(P<0.05),与组织学类型无关,与临床预后无显著相关(P>0.05)。在卵巢癌中,CD147与MMP-2、MMP-3和MMP-9多同时表达,呈现出显著正相关,相关系数分别为0.802,0.786,0.914(P<0.001)。结论:卵巢癌组织中CD147、MMP-2、MMP-3及MMP-9的表达与的临床分期及病理分级有关。MMP-2、MMP-3和MMP-9的分泌增加可能与CD147的诱导促进作用有关系。更多还原

【Abstract】 Objective:To investigate the expressions of MMP-2,MMP-3,MMP-9 and CD147 in human ovarian cancer and their clinicopathological significance.Methods:Immunohisto chemical S-P method was performed to detect the expressions of MMP-2,MMP-3,MMP-9,CD147 in 40 malignant and 9 benign ovarian tumors.Result:The expression rates of MMP-2,MMP-3,MMP-9 and CD147 in ovarian cancer were 92.5%,100%,100% and 95%,respectively.The expressions of MMP-2,MMP-3,MMP-9 and CD147 in ovarian cancer were related with clinical stage and pathological garade(P<0.05)but not with the histological type and clinical prognosis(P>0.05).There were positive correlations between the expressions of CD147 and MMP-2,MMP-3,MMP-9(r=0.802,0.786,0.914)in ovarian cancer.Conclusion:Expressions of CD147,MMP-2,MMP-3 and MMP-9 have relevance to clinical stages and pathological grades in ovarian cancer,and overexpression of CD147 may induce the secretion of MMP-2,MMP-3,MMP-9.更多还原